Attovia Therapeutics | $105,000,000 | (May 14, 2024)
Glacis Labs | $2,000,000 | (May 14, 2024)
hexafarms | $1,403,746 | (May 14, 2024)
Payabli
United States
- Miami , Florida
- 21/03/2023
- Seed
- $12,000,000
Payabli is a Payment Infrastructure and Monetization Platform with a core thesis “If you’re a Software Company you’re a Payments Company”. Payabli helps Software companies make payments a core part of their business model to drive revenue, enhance customer lifetime value, and boost enterprise value.
Payabli is founded by industry veterans with over 18 years of Payments Tech and SaaS experience. We provide developer friendly Pay-In and Pay-Out solutions, lucrative and transparent economics aimed for maximal upside with minimal risk, and a turnkey payments strategy that shaves years off of the learning curve while providing a world-class customer experience to the merchant and end customer. Join the hundreds of partners that are monetizing payments with Payabli today.
- Industry Technology, Information and Internet
- Website https://www.payabli.com/
- LinkedIn https://www.linkedin.com/company/payabli/
CereVasc | $70,000,000 | (May 14, 2024)
GigPig | $1,631,441 | (May 14, 2024)
Active Surfaces | $5,600,000 | (May 14, 2024)
May Health | $25,000,000 | (May 14, 2024)
ByHeart | $95,000,000 | (May 14, 2024)
tiney | $9,034,812 | (May 14, 2024)
Hexis | $2,009,680 | (May 14, 2024)
Nivoda | $30,000,000 | (May 14, 2024)
Switchboard Health | $6,500,000 | (May 14, 2024)